Skip to Main Content

Paper Details

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.
JCO Precis Oncol
11
2022
<i, <i>, Circulating Tumor DNA, FOXO1, Human, Human tumor-derived DNA, Patient, Pediatric Rhabdomyosarcoma, RMS, RMS models, Rhabdomyosarcomas, cancers, children, circulating tumor DNA, ctDNA, gene fusions, mouse, mouse plasma, neoplasms, patient, patients, plasma, tumor
Author NameAffiliation
Mathieu ChicardInstitut Curie
Elisa IzquierdoThe Institute of Cancer Research
Elisa IzquierdoRoyal Marsden NHS Foundation Trust
Ga??lle PierronInstitut Curie
Olivier DelattreINSERM U, PSL Research University, Institut Curie
Didier SurdezINSERM U, PSL Research University, Institut Curie
Didier SurdezBalgrist University Hospital, University of Zurich
Gudrun SchleiermacherInstitut Curie
Gudrun SchleiermacherHospital Group, Institut Curie
Beat W Sch??ferDepartment of Oncology and Children's Research Centre, University Children's Hospital
  • 1 - 10

Datasets

Release 1.2